Atlas Trials

Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma

Clinical trial NCT00186862 · COMPLETED

Trial details

NCT number
NCT00186862
Sponsor
St. Jude Children's Research Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neuroblastoma
Start date
1998-08-01
Primary completion
2000-04-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.